News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
326,653 Results
Type
Article (16182)
Company Profile (298)
Press Release (310165)
Multimedia
Podcasts (87)
Webinars (12)
Section
Business (91884)
Career Advice (172)
Deals (16293)
Drug Delivery (40)
Drug Development (53953)
Employer Resources (31)
FDA (7004)
Job Trends (5584)
News (165825)
Policy (12364)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (978)
Accelerated approval (24)
Adcomms (14)
Allergies (106)
Alliances (26197)
ALS (150)
Alzheimer's disease (1164)
Antibody-drug conjugate (ADC) (321)
Approvals (7278)
Artificial intelligence (324)
Autoimmune disease (184)
Automation (9)
Bankruptcy (111)
Best Places to Work (4797)
BIOSECURE Act (6)
Biosimilars (132)
Biotechnology (232)
Bladder cancer (118)
Brain cancer (55)
Breast cancer (410)
Cancer (3660)
Cardiovascular disease (271)
Career advice (157)
Career pathing (8)
CAR-T (241)
CDC (7)
Cell therapy (628)
Cervical cancer (20)
Clinical research (47144)
Collaboration (1382)
Company closure (2)
Compensation (668)
Complete response letters (51)
COVID-19 (1203)
CRISPR (95)
C-suite (659)
Cystic fibrosis (115)
Data (5098)
Denatured (17)
Depression (115)
Dermatology (36)
Diabetes (293)
Diagnostics (1874)
Digital health (15)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (235)
Drug pricing (51)
Drug shortages (3)
Duchenne muscular dystrophy (257)
Earnings (36742)
Editorial (28)
Employer branding (4)
Employer resources (29)
Events (56388)
Executive appointments (678)
FDA (9113)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (13)
Frontotemporal dementia (26)
Funding (1130)
Gene editing (199)
Generative AI (28)
Gene therapy (554)
GLP-1 (575)
Government (1287)
Grass and pollen (4)
Guidances (192)
Healthcare (7176)
HIV (27)
Huntington's disease (47)
IgA nephropathy (84)
Immunology and inflammation (216)
Immuno-oncology (60)
Indications (110)
Infectious disease (1345)
Inflammatory bowel disease (171)
Inflation Reduction Act (10)
Influenza (61)
Intellectual property (193)
Interviews (18)
IPO (8193)
IRA (13)
Job creations (1046)
Job search strategy (138)
JPM (43)
Kidney cancer (10)
Labor market (25)
Layoffs (251)
Leadership (10)
Legal (2155)
Liver cancer (53)
Longevity (19)
Lung cancer (499)
Lymphoma (280)
Machine learning (28)
Management (7)
Manufacturing (472)
MASH (146)
Medical device (3640)
Medtech (3660)
Mergers & acquisitions (8850)
Metabolic disorders (846)
mRNA (127)
Multiple sclerosis (122)
NASH (14)
Neurodegenerative disease (293)
Neuropsychiatric disorders (78)
Neuroscience (2246)
Neurotech (1)
NextGen: Class of 2026 (2157)
Non-profit (912)
Now hiring (36)
Obesity (382)
Opinion (132)
Ovarian cancer (148)
Pain (123)
Pancreatic cancer (188)
Parkinson's disease (285)
Partnered (14)
Patents (360)
Patient recruitment (431)
Peanut (46)
People (29491)
Pharmaceutical (42)
Pharmacy benefit managers (10)
Phase 1 (16332)
Phase 2 (21721)
Phase 3 (14155)
Pipeline (4757)
Policy (98)
Postmarket research (992)
Preclinical (6845)
Press Release (32)
Prostate cancer (175)
Psychedelics (51)
Radiopharmaceuticals (263)
Rare diseases (786)
Real estate (1902)
Recruiting (12)
Regulatory (11827)
Reports (23)
Research institute (1023)
Resumes & cover letters (20)
Rett syndrome (29)
RNA editing (22)
RSV (21)
Schizophrenia (139)
Series A (214)
Series B (156)
Service/supplier (1)
Sickle cell disease (86)
Special edition (19)
Spinal muscular atrophy (125)
Sponsored (16)
Startups (2221)
State (1)
Stomach cancer (7)
Supply chain (38)
Tariffs (18)
The Weekly (68)
Vaccines (393)
Venture capital (81)
Weight loss (202)
Women's health (37)
Worklife (2)
Date
Today (58)
Last 7 days (422)
Last 30 days (1754)
Last 365 days (18914)
2026 (4779)
2025 (19159)
2024 (21842)
2023 (23967)
2022 (30247)
2021 (31137)
2020 (26588)
2019 (18342)
2018 (13442)
2017 (15635)
2016 (13739)
2015 (16811)
2014 (12452)
2013 (9312)
2012 (9526)
2011 (9706)
2010 (9313)
Location
Africa (208)
Alabama (69)
Alaska (2)
Arizona (85)
Arkansas (6)
Asia (31555)
Australia (4613)
California (7872)
Canada (2150)
China (1011)
Colorado (274)
Connecticut (283)
Delaware (259)
Europe (47383)
Florida (1018)
Georgia (230)
Hawaii (2)
Idaho (17)
Illinois (456)
India (56)
Indiana (186)
Iowa (8)
Japan (410)
Kansas (86)
Kentucky (10)
Louisiana (12)
Maine (13)
Maryland (859)
Massachusetts (6322)
Michigan (122)
Minnesota (301)
Mississippi (3)
Missouri (36)
Montana (17)
Nebraska (6)
Nevada (48)
New Hampshire (21)
New Jersey (1956)
New Mexico (13)
New York (1996)
North Carolina (917)
North Dakota (6)
Northern California (3917)
Ohio (189)
Oklahoma (11)
Oregon (24)
Pennsylvania (1441)
Puerto Rico (9)
Rhode Island (28)
South America (282)
South Carolina (10)
Southern California (3138)
Tennessee (46)
Texas (1028)
United States (26358)
Utah (127)
Virginia (159)
Washington D.C. (38)
Washington State (642)
West Virginia (1)
Wisconsin (53)
326,653 Results for "chemomab therapeutics ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Chemomab Therapeutics Announces Year End and Fourth Quarter 2025 Financial Results and Provides a Corporate Update
March 19, 2026
·
16 min read
Press Releases
Chemomab Therapeutics to Participate in Oppenheimer 36th Annual Healthcare Life Sciences Conference
February 17, 2026
·
1 min read
Press Releases
Chemomab Therapeutics Announces Third Quarter 2025 Financial Results and Provides Corporate Update
November 21, 2025
·
12 min read
Press Releases
Chemomab to Participate in Oppenheimer’s Movers in Rare Disease Summit 2025
November 24, 2025
·
2 min read
Press Releases
Chemomab Therapeutics Announces Nebokitug Phase 2 SPRING Trial Results in Primary Sclerosing Cholangitis Published in the American Journal of Gastroenterology
December 3, 2025
·
11 min read
Press Releases
Chemomab Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference
August 22, 2025
·
2 min read
Press Releases
Chemomab Therapeutics Announces Second Quarter 2025 Financial Results and Provides Corporate Update
August 15, 2025
·
15 min read
Press Releases
YUVEZZI™ from Tenpoint Therapeutics, Ltd. Is Now Available Nationwide Across the United States
March 30, 2026
·
6 min read
Chemomab Therapeutics to Participate in Upcoming Scientific Conferences - May 17, 2024
Chemomab Therapeutics Ltd. today announced upcoming scientific presentations at the Gordon Research Conference on Chemotactic Cytokines and at EASL 2024, the Annual Congress of the European Association for the Study of the Liver.
May 17, 2024
·
3 min read
Press Releases
Chemomab Announces Multiple Presentations at AASLD The Liver Meeting® 2025 Featuring Clinical Data from the Nebokitug Phase 2 Trial in Primary Sclerosing Cholangitis
November 7, 2025
·
10 min read
1 of 32,666
Next
